Which liquid biopsy analytes have the highest potential for improved patient stratification in clinical trials within the next 5 years?
Vote below
173 votes
Cell-free DNA
44%
116 votes
Circulating tumor cells
29%
48 votes
Exosomes / extracellular vesicles
12%
29 votes
Cell-free RNA / miRNA
7%
30 votes
Multiple analytes
8%
Votes